Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $39.72 in the prior trading day, Cogent Biosciences Inc (NASDAQ: COGT) closed at $40.39, up 1.69%. In other words, the price has increased by $1.69 from its previous closing price. On the day, 2.88 million shares were traded. COGT stock price reached its highest trading level at $40.75 during the session, while it also had its lowest trading level at $39.59.
Ratios:
Our goal is to gain a better understanding of COGT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.38 and its Current Ratio is at 6.38. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.19.
On November 10, 2025, Stifel Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $40.
On October 16, 2025, Stifel started tracking the stock assigning a Hold rating and target price of $16.Stifel initiated its Hold rating on October 16, 2025, with a $16 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 10 ’25 when Fairmount Funds Management LLC bought 2,777,777 shares for $9.00 per share. The transaction valued at 24,999,993 led to the insider holds 9,003,418 shares of the business.
Pinnow Cole bought 43,750 shares of COGT for $332,412 on Jan 14 ’25. The Chief Commercial Officer now owns 45,848 shares after completing the transaction at $7.60 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, COGT now has a Market Capitalization of 6200089600 and an Enterprise Value of 5531172352.
Stock Price History:
The Beta on a monthly basis for COGT is 0.36, which has changed by 3.2471085 over the last 52 weeks, in comparison to a change of 0.12934029 over the same period for the S&P500. Over the past 52 weeks, COGT has reached a high of $39.86, while it has fallen to a 52-week low of $3.72. The 50-Day Moving Average of the stock is 98.71%, while the 200-Day Moving Average is calculated to be 260.64%.
Shares Statistics:
The stock has traded on average 2.95M shares per day over the past 3-months and 3788050 shares per day over the last 10 days, according to various share statistics. A total of 139.83M shares are outstanding, with a floating share count of 122.89M. Insiders hold about 19.18% of the company’s shares, while institutions hold 87.37% stake in the company. Shares short for COGT as of 1763078400 were 15477473 with a Short Ratio of 5.25, compared to 1760486400 on 16276722. Therefore, it implies a Short% of Shares Outstanding of 15477473 and a Short% of Float of 11.310001.
Earnings Estimates
The stock of Cogent Biosciences Inc (COGT) is currently in the spotlight, with 11.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.49, with high estimates of -$0.38 and low estimates of -$0.61.
Analysts are recommending an EPS of between -$1.96 and -$2.47 for the fiscal current year, implying an average EPS of -$2.25. EPS for the following year is -$1.73, with 11.0 analysts recommending between -$0.88 and -$2.25.
